BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6275893)

  • 1. Fluid phase activation of proenzymic C1r purified by affinity chromatography.
    Villiers CL; Duplaa AM; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1982 Jan; 700(1):118-26. PubMed ID: 6275893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proenzymic C1s associated with catalytic amounts of C1r. Study of the activation process.
    Arlaud GJ; Reboul A; Colomb MG
    Biochim Biophys Acta; 1977 Nov; 485(1):227-35. PubMed ID: 303116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage.
    Arlaud GJ; Villiers CL; Chesne S; Colomb MG
    Biochim Biophys Acta; 1980 Nov; 616(1):116-29. PubMed ID: 6254570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of proenzymic and activated human C1s free ofC1r. Effect of calcium and ionic strength on activated C1s.
    Arlaud GJ; Reboul A; Meyer CM; Colomb MG
    Biochim Biophys Acta; 1977 Nov; 485(1):215-25. PubMed ID: 911862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
    Bauer J; Valet G
    Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical data on C1 intrinsic activation (author's transl)].
    Colomb MG; Bensa JC; Villiers CL; Arlaud GJ
    Ann Immunol (Paris); 1982; 133C(2):155-64. PubMed ID: 6287903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human C1r: Western blot analysis reveals slow and dose-dependent activation.
    Hosoi S; Borsos T
    J Immunol; 1988 Sep; 141(5):1610-4. PubMed ID: 2842400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s.
    Sim RB; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1980 Apr; 612(2):433-49. PubMed ID: 6245704
    [No Abstract]   [Full Text] [Related]  

  • 11. Autocatalytic activation of C1r subcomponent of the first component of human complement.
    Kasahara Y; Odai H; Takahashi K; Nagasawa S; Koyama J
    J Biochem; 1985 Jan; 97(1):365-72. PubMed ID: 2987200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and efficient method for the purification of the complement subcomponents C1r and C1s in zymogen form using fast protein chromatography.
    Peitsch MC; Kovacsovics TJ; Isliker H
    J Immunol Methods; 1988 Apr; 108(1-2):265-9. PubMed ID: 2832479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
    McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the activation of the human C1r complement molecule.
    Bauer J; Valet G
    Mol Immunol; 1982 Mar; 19(3):487-95. PubMed ID: 6285181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.
    Lacroix MB; Aude CA; Arlaud GJ; Colomb MG
    Biochem J; 1989 Feb; 257(3):885-91. PubMed ID: 2539098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoactivation of human complement subcomponent C1r involves structural changes reflected in modifications of intrinsic fluorescence, circular dichroism and reactivity with monoclonal antibodies.
    Villiers CL; Arlaud GJ; Colomb MG
    Biochem J; 1983 Nov; 215(2):369-75. PubMed ID: 6316926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation.
    Spycher SE; Nick H; Rickli EE
    Eur J Biochem; 1986 Apr; 156(1):49-57. PubMed ID: 3007145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of human complement subcomponents C1r and C1s in their unactivated, proenzyme forms.
    Lane PD; Schumaker VN; Tseng Y; Poon PH
    J Immunol Methods; 1991 Aug; 141(2):219-26. PubMed ID: 1880428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.